Lindsay Leggett, PA
Physician Assistant · Wailuku, HINPI 1598005746
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,488 of the $4,264 with a category attached, or 81.8%. 24 manufacturers reported payments, led by Astellas Pharma US Inc at 32.1% of the total. Among physician assistant clinicians in HI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 156 payments — averaging $27.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$1K
- Pfizer$871
- AbbVie$538
- Bayer$331
- Johnson & Johnson$272
- Boston Scientific$104
- plus $781 from 18 others
What the payments were for
- Food & beverage$3,48882%
- Education$77618%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 39 | $1,368 |
| Pfizer | 30 | $871 |
| AbbVie | 29 | $538 |
| Bayer | 6 | $331 |
| Johnson & Johnson | 12 | $272 |
| Boston Scientific | 3 | $104 |
| 180 Medical, Inc. | 5 | $101 |
| Myovant Sciences Inc. | 5 | $96 |
| Teleflex LLC | 4 | $80 |
| ABC Home Medical Supply, Inc. | 4 | $78 |
| Seagen Inc. | 1 | $55 |
| Endo Pharmaceuticals Inc. | 3 | $53 |
| C. R. Bard, Inc. & Subsidiaries | 3 | $48 |
| Urogen Pharma, Inc. | 2 | $45 |
| Medtronic | 1 | $31 |
| Angiodynamics, Inc. | 1 | $26 |
| Convatec Inc. | 1 | $24 |
| Endo USA, Inc. | 1 | $24 |
| Merck | 1 | $23 |
| RGH Enterprises LLC | 1 | $22 |
| E.r. Squibb & Sons, L.L.C. | 1 | $22 |
| Axonics, Inc. | 1 | $21 |
| Tolmar, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,264 in reported general payments places this provider in the 90th percentile of 246 physician assistant providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XtandiEnzalutamide | 15 | $215,545 |
| MyrbetriqMirabegron | 85 | $62,972 |
| Tamsulosin Hcl | 465 | $9,257 |
| Abiraterone Acetate | 16 | $8,969 |
| Finasteride | 288 | $6,215 |
| Solifenacin Succinate | 100 | $5,192 |
| Potassium Citrate ErPotassium Citrate | 55 | $4,283 |
| Silodosin | 43 | $4,037 |
| Tolterodine Tartrate ErTolterodine Tartrate | 23 | $3,378 |
| Methenamine Hippurate | 38 | $3,037 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 127 | $2,886 |
| Dutasteride | 37 | $2,802 |
| Testosterone Cypionate | 81 | $2,529 |
| Trospium Chloride | 18 | $2,166 |
| Testosterone | 16 | $1,449 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncXtandi, Myrbetriq | $1,368 | $278,517100 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 246 physician assistant providers in Hawaii.
Other physician assistant in Wailuku
- Scott SmithWailuku$1K
- Brooke GarciaMililani$381K
- Eric YukumotoHonolulu$41K
- Dorothy MauriceHonolulu$39K
- Patricia AchayKailua Kona$22K
- Marne Carmichael WalshHilo$17K
- Edie HamiltonKahului$13K
- Joycelyn ChunHonolulu$11K
- Rachel InouyeHonolulu$11K
- Jeffrey MankAiea$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.